Longitudinal evaluation of cardiovascular disease-associated biomarkers in relation to abacavir therapy.
Hammond
Emma
E
Centre for Clinical Immunology and Biomedical Statistics, Murdoch University, South Street, Murdoch, Western Australia 6150, Australia. E.Hammond@murdoch.edu.au
McKinnon
Elizabeth
E
Mallal
Simon
S
Nolan
David
D
D054316:Biomarkers, Pharmacological / Q000378:metabolism; D015224:Dideoxynucleosides / Q000009:adverse effects*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D009203:Myocardial Infarction / Q000139:chemically induced / Q000517:prevention & control*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D000099227:Abacavir
D054316:Biomarkers, Pharmacological; D015224:Dideoxynucleosides; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir